Guidance values for surface monitoring of antineoplastic drugs in German pharmacies

Rudolf Schierl1, Antje Böhlandt, Dennis Nowak

  • 1Institute and Outpatient Clinic for Occupational, Social and Environmental Medicine, Ludwig-Maximilians-University Munich, Ziemssenstrasse 1, D-80336 Muenchen, Germany. Rudolf.Schierl@med.uni-muenchen.de

Abstract

Insights

Surface monitoring in German pharmacies found antineoplastic drug contamination. Threshold guidance values (TGVs) were proposed to assess and improve occupational safety for handling cytotoxic drugs like platinum and 5-fluorouracil.

Area of Science:

  • Occupational Health
  • Environmental Monitoring
  • Pharmaceutical Sciences

Background:

  • Antineoplastic drugs are vital in cancer therapy but pose risks due to their cytotoxic, carcinogenic, mutagenic, or teratogenic properties.
  • Evaluating personal exposure to these hazardous drugs is crucial for healthcare worker safety.
  • Surface monitoring has been established as a reliable method for assessing contamination levels in pharmacy settings.

Purpose of the Study:

  • To statistically describe a dataset of surface contamination from antineoplastic drugs in German pharmacies.
  • To propose Threshold Guidance Values (TGVs) to aid in the interpretation of surface monitoring results.
  • To provide a benchmark for evaluating and improving occupational safety practices.

Main Methods:

  • Wipe sampling was conducted in 102 German pharmacies.
  • Concentrations of platinum (PT) and 5-fluorouracil (FU) were measured using validated analytical techniques (voltammetry for PT, GC/MS for FU).
  • Data were stratified by location and statistically analyzed to establish TGVs.

Main Results:

  • Contamination by PT and FU was detected on all surfaces, with higher levels on storage shelves and floors.
  • Median contamination levels ranged from 0.20-1.70 pg cm⁻² for PT and 2.50-10.00 pg cm⁻² for FU.
  • The 75th percentiles were 3.92 pg cm⁻² for PT and 28.90 pg cm⁻² for FU, forming the basis for TGV 2.

Conclusions:

  • The proposed TGVs (TGV 1 at median, TGV 2 at 75th percentile) facilitate the interpretation of contamination monitoring results.
  • Results below TGV 1 indicate good working practices, while exceeding TGV 2 necessitates optimization of handling procedures.
  • Implementing TGVs aids in reducing occupational exposure and enhances pharmacy personnel's ability to benchmark and improve safety.

Related Concept Videos

Therapeutic Drug Monitoring: Drug Analysis Methods01:26

Therapeutic Drug Monitoring: Drug Analysis Methods

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
Therapeutic Drug Monitoring: Overview and Classification01:16

Therapeutic Drug Monitoring: Overview and Classification

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
Dosage Regimen: Individualization01:24

Dosage Regimen: Individualization

Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
Drug Concentrations: Measurements01:23

Drug Concentrations: Measurements

Drug concentration is the quantity of a drug present in a biological sample. Measuring drug amounts in biological samples allows the clinician to understand how a drug is absorbed, distributed, metabolized, and excreted. Samples can be obtained through invasive or non-invasive methods. Invasive techniques involve surgical or parenteral interventions to gather blood, cerebrospinal fluid, or tissue biopsy. Conversely, non-invasive approaches provide samples like urine, feces, and saliva.
Plasma —...